Facet Biotech Corporation
(Public, NASDAQ:FACT) Watch this stockFind more results for
FACT
Advertisement
Events
Nov 3, 2009
Q3 2009 FACET BIOTECH CORP Earnings Conference Call -
Nov 3, 2009
Q3 2009 FACET BIOTECH CORP Earnings Release
Sep 10, 2009
FACET BIOTECH CORP at Thomas Weisel Partners Healthcare Conference
|
More events from AOL Finance »
|
Key stats and ratios
| Q3 (Sep '09) | 2008 | |
| Net profit margin | -377.17% | -886.02% |
| Operating margin | -389.88% | -876.38% |
| EBITD margin | - | -765.85% |
| Return on average assets | -34.70% | -35.68% |
| Return on average equity | -46.32% | -46.34% |
| Employees | 327 | - |
Address
Website links
Company website:
http://www.facetbiotech.com/
http://www.facetbiotech.com/
External links
Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Options - Morningstar
Research Reports - Yahoo Finance
Facet Biotech Corporation discussed on blogs
Value Stocks in Drugs & Biotech (AMGN, BIIB, CBST, CEPH, PDLI ...
- 247admin
- BioHealth Investor
- 3 hours ago
Ranking 1500+ Small Cap Stocks by Year-to-Date Performance ...
- Investor's Resources
- NASD100.com - Daily Stock Rankings
- Nov 20, 2009
Facet Biotech Corporation discussions
View all discussions »Description
Facet Biotech Corporation is a biotechnology company. The Company is engaged in identifying and developing oncology therapeutics. It has four antibodies in the clinic for oncology and immunologic disease indications, of which two are in phase II and two in phase I. The Company has several investigational compounds in various stages of development for the treatment of cancer and immunologic diseases, three of which it is developing with collaboration partners: two with Biogen Idec and one with BMS. The spin-off of Facet Biotech from PDL was effected on December 18, 2008.
Officers and directors
| Faheem Hasnain | President, Chief Executive Officer, Director | |
| Andrew L. Guggenhime | Chief Financial Officer, Senior Vice President | |
| Mark Anthony McCamish M.D., Ph.D. | Senior Vice President, Chief Medical Officer | |
| Ted Llana Ph.D. | Senior Vice President - Commercial and Corporate Development | |
| Maninder Hora Ph.D. | Vice President - Product and Quality Operations | |
| Francis Willard Sarena | Vice President, General Counsel, Secretary | |
| Herbert C. Cross | Principal Accounting Officer, Corpoarte Controller | |
| Bradford S. Goodwin CPA | Director | |
| David Ross Parkinson M.D. | Director | |
| Gary A. Lyons | Director |